This website is intended for healthcare professionals. If you are a member of the public, please click here


<font size="4.5">What is FERACCRU<sup>®</sup></font>


FERACCRU® is an oral treatment for iron deficiency (ID) in adults.1


Each capsule contains 30 mg of iron as ferric maltol1

  • FERACCRU® should be taken twice a day and swallowed whole on an empty stomach with water.
  • FERACCRU® should not be used in inflammatory bowel disease (IBD) flare or in IBD patients with haemoglobin (Hb) <9.5 g/dL.1

For further information on special warnings, precautions and contraindications, please refer to the GB SPC or NI SPC.

                                                                 For illustrative purposes only, not actual size

Key benefits of FERACCRU® from the AEGIS trials  

FERACCRU® relieved IDA in patients with IBD (without flare) by 12 weeks vs placebo in 66% of patients2

FERACCRU® was well-tolerated vs placebo2,3

FERACCRU® short-term (12 weeks) or long-term (up to 64 weeks) therapy did not lead to iron overload4